Tag Archives: Glutamatergic Receptor Systems

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

Summary Early evening headlines yesterday, on BBC Radio 4 news, announced the “shocking” news that drugs for Alzheimer’s Disease / dementia had been de-listed in France. This story has not been followed-up, and appears to have been dropped quietly; although … Continue reading

Posted in Alzheimer’s Disease International (ADI), Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Alzheimer’s Disease and Metals: a Review

Summary This review investigates the potential role(s) of metals in the development of Alzheimer’s Disease. Full Text Link Reference Amadoruge, PC. Barnham, KJ. (2011). Alzheimer’s disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling. International … Continue reading

Posted in For Researchers (mostly), Universal Interest | Tagged , , , , , , , , | Leave a comment